Manipal Health Enterprises Limited Holds 16th AGM on Sept 29, 2026
Manipal Health Enterprises Limited held its 16th AGM on September 29, 2026. FY26 revenue rose 25.4% to ₹10,336 crore, with profit at ₹917 crore. The company expanded its network with acquisitions and new facilities. Key agenda items included financial statement adoption, director appointments, and ESOP plan approval.
The AGM summary includes important financial performance details for the previous fiscal year and outlines key corporate actions approved, which are material to stakeholders.
The announcement is a factual summary of the AGM proceedings and financial highlights, without any significant positive or negative developments that would sway the sentiment.
Manipal Health Enterprises Limited (formerly Manipal Health Enterprises Private Limited) held its 16th Annual General Meeting (AGM) on September 29, 2026, commencing at 11:00 AM IST through Video Conferencing. The meeting was conducted in accordance with the Companies Act, 2013, and SEBI regulations.
During the financial year 2025-26, the company reported significant growth. Revenue from operations increased by 25.4% to ₹10,336 crore, with operating EBITDA reaching ₹2,644 crore, maintaining an EBITDA margin of 25.6%. Profit for the year stood at ₹917 crore. Inpatient volumes grew to 5.27 Lakhs from 4.39 Lakhs, and outpatient volumes increased to 54.83 Lakhs from 47.17 Lakhs. The company expanded its network by acquiring Sahyadri Hospitals Private Limited and operationalizing two new greenfield facilities.
The AGM transacted several ordinary and special businesses. These included the adoption of audited standalone and consolidated financial statements for FY 2025-26, the appointment/re-appointment of directors, and the appointment of statutory and secretarial auditors. Special businesses involved the approval of the Employee Stock Option Plan 2024, ratification of benefits to subsidiaries, approval of an Upside Sharing Arrangement, amendments to the Articles of Association, and fixation of the term for Dr. Ranjan Ramdas Pai as a Non-Executive Director.
The meeting concluded at 12:08 PM IST after a Question & Answer session. Voting results, along with the Scrutinizer’s Report, will be disseminated to the stock exchanges and posted on the company's website.
What to do with a filing like this
Manipal Health Enterprises Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Manipal Health Enterprises Limited. Read the original for the full detail.